PharmTech1d
FDA Approves RSV Vaccine
Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...
High-resolution images of RSV may expose stubborn virus's weak points
The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...
Armed robbery in Revesby1d
FDA Clears Pfizer RSV Vaccine for At-Risk Adults 18-59
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine ...
Pharmabiz19h
Pfizer receives US FDA approval for its RSV vaccine Abrysvo for adults aged 18 to 59 at increased risk for disease
In the prefusion state, the RSV fusion protein (F) is a major target of neutralizing antibodies, serving as the basis of Pfizer’s RSV vaccine. Variations in the F protein sequence among RSV-A and ...
technologynetworks3d
RSV pre-F Protein: Innovative Tool for Structure-Based Vaccine Evaluation
The trimeric pre-fusion glycoprotein F is essential for accurately assessing the immunogenicity of RSV vaccines. We strictly adhere to ... whether it comes through recombinant proteins, antibodies, ...
Medpage Today on MSN6d
Novel Monoclonal Antibody Protects Infants Against RSV
"Clesrovimab administered as a single dose for infants of all weights provided protection against mild, moderate, and severe ...
Medscape14d
Rapid Antigen-based Testing for Respiratory Syncytial Virus
Most assays target the RSV fusion surface glycoprotein. The color change is mediated by the binding of viral protein from the sample to the test's RSV-specific antibodies. The apparatus ...
The New England Journal of Medicine1mon
Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...
Science Daily24d
New images of RSV may expose stubborn virus's weak points
RSV F proteins sit on the viral surface, ready to engage with host cell receptors and regulate the virus's fusion and entry into the host cell. The scientists' images reveal that in RSV ...
EurekAlert!23d
New images of RSV may expose stubborn virus’s weak points
RSV F proteins sit on the viral surface, ready to engage with host cell receptors and regulate the virus’s fusion and entry into the host cell. The scientists’ images reveal that in RSV ...
Phys.org24d
High-resolution images of RSV may expose stubborn virus's weak points
RSV F proteins sit on the viral surface, ready to engage with host cell receptors and regulate the virus's fusion and entry into the host cell. The scientists' images reveal that in RSV ...
technologynetworks23d
New Images of RSV May Expose the Stubborn Virus’s Weak Points
RSV F proteins sit on the viral surface, ready to engage with host cell receptors and regulate the virus’s fusion and entry into the host cell. The scientists’ images reveal that in RSV, two F ...